Concert Pharmaceuticals CEO Roger Tung's 2020 pay rises 9% to $3M
Concert Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Concert Pharmaceuticals reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, three executives at Concert Pharmaceuticals received on average a compensation package of $2M, a 7% decrease compared to previous year.
Average pay of disclosed executives at Concert Pharmaceuticals
Roger D. Tung, Chief Executive Officer, received $3M in total, which increased by 9% compared to 2019. 36% of Tung's compensation, or $1.1M, was in stock awards. Tung also received $320K in non-equity incentive plan, $1M in option awards, $582K in salary, as well as $12K in other compensation.
Nancy Stuart, Chief Operating Officer, received a compensation package of $1.6M. 31% of the compensation package, or $493K, was in stock awards.
James V. Cassella, Chief Development Officer, earned $1.3M in 2020, a 24% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2021.